NCT06623318View on ClinicalTrials.gov

IV Ensure in Patients Receiving OPAT

NARecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

August 23, 2023

Primary Completion Date

October 15, 2024

Study Completion Date

November 30, 2024

Conditions
Determine If Adherence Rates with IV Antibiotics in OPAT Have a Correlation to Hospital Readmission Rates
Interventions
DEVICE

Remote therapeutic monitoring device

IV Ensure proprietary remote therapeutic monitoring device is used to record and transmit data associated with date, time, and duration of IV medications administered in the home setting post-acute.

Trial Locations (1)

73104

RECRUITING

The University of Oklahoma Health Sciences Center, Oklahoma City

All Listed Sponsors
collaborator

University of Oklahoma

OTHER

lead

IV Ensure

INDUSTRY